Cumberland Pharmaceuticals (CPIX) EBITDA Margin Growth (3y) (2013 - 2026)
Cumberland Pharmaceuticals (CPIX) EBITDA Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1,673.00 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -37.00 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -5,395.00 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -1,442.00 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -1,299.00 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 5,091.00 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5,193.00 |
| 10 | Cumberland Pharmaceuticals | 104.57 Mn | 93.23 Mn | 7.20 Mn | -1,767.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,767.00 |
| Dec 31, 2025 | 1,494.00 |
| Sep 30, 2025 | -2,117.00 |
| Jun 30, 2025 | 1,103.00 |
| Mar 31, 2025 | 2,259.00 |
| Dec 31, 2024 | 3,468.00 |
| Sep 30, 2024 | 72.00 |
| Jun 30, 2024 | 543.00 |
| Mar 31, 2024 | -1,892.00 |
| Dec 31, 2023 | -4,905.00 |
| Sep 30, 2023 | -544.00 |
| Jun 30, 2023 | 1,668.00 |
| Mar 31, 2023 | 555.00 |
| Dec 31, 2022 | 1,151.00 |
| Sep 30, 2022 | 4,356.00 |
| Jun 30, 2022 | -335.00 |
| Mar 31, 2022 | 360.00 |
| Dec 31, 2021 | -3,557.00 |
| Sep 30, 2021 | 191.00 |
| Jun 30, 2021 | -731.00 |